{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:11:15Z","timestamp":1791252675586,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1681\/asn.2010040345","type":"journal-article","created":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T23:43:04Z","timestamp":1285285384000},"page":"2041-2046","source":"Crossref","is-referenced-by-count":68,"title":["VHL Inactivation Induces HEF1 and Aurora Kinase A"],"prefix":"10.1681","volume":"21","author":[{"given":"Jianyong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huapeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Harten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick H.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duanqing","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20230423","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cell.2009.03.023","article-title":"The vertebrate primary cilium in development, homeostasis, and disease","volume":"137","author":"Gerdes","year":"2009","journal-title":"Cell"},{"key":"R2-9-20230423","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrm952","article-title":"Intraflagellar transport","volume":"3","author":"Rosenbaum","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R3-9-20230423","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.cell.2007.04.035","article-title":"HEF1-dependent Aurora A activation induces disassembly of the primary cilium","volume":"129","author":"Pugacheva","year":"2007","journal-title":"Cell"},{"key":"R4-9-20230423","doi-asserted-by":"crossref","first-page":"14320","DOI":"10.1074\/jbc.272.22.14320","article-title":"Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1)","volume":"272","author":"Sattler","year":"1997","journal-title":"J Biol Chem"},{"key":"R5-9-20230423","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1097\/01.ASN.0000141055.57643.E0","article-title":"Intraflagellar transport and cilia-dependent renal disease: The ciliary hypothesis of polycystic kidney disease","volume":"15","author":"Pazour","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R6-9-20230423","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome","volume":"2","author":"Kaelin","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"R7-9-20230423","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1535-6108(02)00071-5","article-title":"HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron","volume":"1","author":"Mandriota","year":"2002","journal-title":"Cancer Cell"},{"key":"R8-9-20230423","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00109-008-0364-9","article-title":"The expanding universe of hypoxia","volume":"86","author":"Zhang","year":"2008","journal-title":"J Mol Med"},{"key":"R9-9-20230423","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrm1366","article-title":"Oxygen sensing by HIF hydroxylases","volume":"5","author":"Schofield","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R10-9-20230423","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1097-2765(00)80096-9","article-title":"The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix","volume":"1","author":"Ohh","year":"1998","journal-title":"Mol Cell"},{"key":"R11-9-20230423","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1681\/ASN.2006020181","article-title":"Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein","volume":"17","author":"Esteban","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R12-9-20230423","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1158\/0008-5472.CAN-06-0501","article-title":"Primary cilium formation requires von hippel-lindau gene function in renal-derived cells","volume":"66","author":"Lutz","year":"2006","journal-title":"Cancer Res"},{"key":"R13-9-20230423","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1083\/jcb.200605092","article-title":"The von Hippel-Lindau tumor suppressor protein controls ciliogenesis by orienting microtubule growth","volume":"175","author":"Schermer","year":"2006","journal-title":"J Cell Biol"},{"key":"R14-9-20230423","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/ncb1579","article-title":"pVHL and GSK3beta are components of a primary cilium-maintenance signalling network","volume":"9","author":"Thoma","year":"2007","journal-title":"Nat Cell Biol"},{"key":"R15-9-20230423","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1091\/mbc.e08-01-0042","article-title":"Transcriptional regulation of serine\/threonine kinase-15 (STK15) expression by hypoxia and HIF-1","volume":"19","author":"Klein","year":"2008","journal-title":"Mol Biol Cell"},{"key":"R16-9-20230423","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.urolonc.2006.06.001","article-title":"Significance of Aurora-A expression in renal cell carcinoma","volume":"25","author":"Kurahashi","year":"2007","journal-title":"Urol Oncol"},{"key":"R17-9-20230423","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5","article-title":"Antigens recognized by autologous antibody in patients with renal-cell carcinoma","volume":"83","author":"Scanlan","year":"1999","journal-title":"Int J Cancer"},{"key":"R18-9-20230423","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1634\/stemcells.2006-0398","article-title":"Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxia","volume":"25","author":"Martin-Rendon","year":"2007","journal-title":"Stem Cells"},{"key":"R19-9-20230423","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.advenzreg.2008.12.005","article-title":"Identification of novel VHL regulated genes by transcriptomic analysis of RCC10 renal carcinoma cells","volume":"49","author":"Harten","year":"2009","journal-title":"Adv Enzyme Regul"},{"key":"R20-9-20230423","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1091\/mbc.e08-06-0566","article-title":"Regulation of renal epithelial tight junctions by the von Hippel-Lindau tumor suppressor gene involves occludin and claudin 1 and is independent of E-cadherin","volume":"20","author":"Harten","year":"2009","journal-title":"Mol Biol Cell"},{"key":"R21-9-20230423","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ncb899","article-title":"Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL","volume":"5","author":"Hergovich","year":"2003","journal-title":"Nat Cell Biol"},{"key":"R22-9-20230423","doi-asserted-by":"crossref","first-page":"22205","DOI":"10.1074\/jbc.M503220200","article-title":"Tumor suppression by the von Hippel-Lindau protein requires phosphorylation of the acidic domain","volume":"280","author":"Lolkema","year":"2005","journal-title":"J Biol Chem"},{"key":"R23-9-20230423","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1128\/MCB.25.13.5675-5686.2005","article-title":"Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma","volume":"25","author":"Raval","year":"2005","journal-title":"Mol Cell Biol"},{"key":"R24-9-20230423","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1371\/journal.pbio.0000083","article-title":"Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth","volume":"1","author":"Kondo","year":"2003","journal-title":"PLoS Biol"},{"key":"R25-9-20230423","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1158\/0008-5472.CAN-05-2670","article-title":"Regulation of E-cadherin expression by VHL and hypoxia-inducible factor","volume":"66","author":"Esteban","year":"2006","journal-title":"Cancer Res"},{"key":"R26-9-20230423","first-page":"4184","article-title":"von Hippel-Lindau protein promotes the assembly of actin and vinculin and inhibits cell motility","volume":"61","author":"Kamada","year":"2001","journal-title":"Cancer Res"},{"key":"R27-9-20230423","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1517\/14728220903307483","article-title":"Aurora-A kinase: A novel target both for cellular immunotherapy and molecular target therapy against human leukemia","volume":"13","author":"Ochi","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"R28-9-20230423","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/ncponc0106","article-title":"Drug insight: Histone deacetylase inhibitors\u2013development of the new targeted anticancer agent suberoylanilide hydroxamic acid","volume":"2","author":"Kelly","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"key":"R29-9-20230423","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1038\/onc.2009.224","article-title":"Nedd9\/Hef1\/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity","volume":"28","author":"Bui","year":"2009","journal-title":"Oncogene"},{"key":"R30-9-20230423","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1158\/0008-5472.CAN-09-2110","article-title":"Human enhancer of filamentation 1 is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells","volume":"70","author":"Kim","year":"2010","journal-title":"Cancer Res"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201012000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:33:04Z","timestamp":1786131184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201012000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2010040345","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}